Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 261 to 270 of 341

TitleReference numberPublishedLast updated
Ceritinib for previously treated anaplastic lymphoma kinase positive non-small-cell lung cancerTA395
Haematological cancers: improving outcomesNG47
Prolaris gene expression assay for assessing long-term risk of prostate cancer progressionMIB65
Topotecan, pegylated liposomal doxorubicin hydrochloride, paclitaxel, trabectedin and gemcitabine for treating recurrent ovarian cancerTA389
Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)TA23
Skin cancer preventionPH32
Enzalutamide for treating metastatic hormone-relapsed prostate cancer before chemotherapy is indicatedTA377
Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapyTA378
Bladder cancerQS106
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapyTA374

Results per page

  1. 10
  2. 25
  3. 50
  4. All